# Therascreen® KRAS RGQ PCR Kit

> **NCT05347745** · NA · COMPLETED · sponsor: **QIAGEN Gaithersburg, Inc** · enrollment: 219 (actual)

## Conditions studied

- Colo-rectal Cancer

## Interventions

- **DIAGNOSTIC_TEST:** therascreen® KRAS RGQ PCR Kit

## Key facts

- **NCT ID:** NCT05347745
- **Lead sponsor:** QIAGEN Gaithersburg, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-07
- **Primary completion:** 2023-03-30
- **Final completion:** 2023-04-30
- **Target enrollment:** 219 (ACTUAL)
- **Last updated:** 2025-03-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05347745

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05347745, "Therascreen® KRAS RGQ PCR Kit". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05347745. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*